NEW YORK (360Dx) – A quantitative interferon-gamma release assay can identify young children with latent tuberculosis who are at risk of developing active cases of the disease, according to a new study.

The researchers added that their findings could lead to changes in international guidelines, which currently do not recommend the use of such tests in children.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.